| P2093 | author name string | K Fan Chung | |
| P2860 | cites work | The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor | Q24311786 |
| | The pharmacological basis of anti-IgE therapy | Q28143946 |
| | Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits | Q30460135 |
| | Inhibition of IgE synthesis by anti-IgE: role in long-term inhibition of IgE synthesis by neonatally administered soluble IgE. | Q33559272 |
| | Humanized anti-IgE mAb Hu-901 prevents the activation of allergen-specific T cells | Q40812180 |
| | Peptide blocking of IgE/receptor interaction: possibilities and pitfalls | Q41693762 |
| | Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens | Q42155789 |
| | Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). | Q43694602 |
| | Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma | Q43701894 |
| | The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics | Q43723871 |
| | Omalizumab improves asthma-related quality of life in children with allergic asthma | Q44204121 |
| | The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma | Q44227362 |
| | Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. | Q51690286 |
| | Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality. | Q51722262 |
| | Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. | Q53461102 |
| | Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. | Q55066450 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| | monoclonal antibody | Q422248 |
| | allergic asthma | Q12301086 |
| P304 | page(s) | 439-446 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Expert Opinion on Pharmacotherapy | Q5421212 |
| P1476 | title | Anti-IgE monoclonal antibody, omalizumab: a new treatment for allergic asthma | |
| P478 | volume | 5 | |